Related by context. Frequent words. (Click for all words.) 64 Phase Ib II 64 bicifadine 63 phase IIa clinical 63 phase IIb clinical 61 Pivotal Phase III 61 MERLIN TIMI 61 forodesine 60 desvenlafaxine 60 deforolimus 60 Progenics Pharmaceuticals 60 phase Ib 60 Phase IIIb 60 phase IIa 59 Phase Ib clinical 59 Bicifadine 59 almorexant 58 SAR# [004] 58 phase IIb 58 WILEX 58 clinical 58 REG1 58 Azedra 58 Icatibant 58 Phase IIB 58 eResearchTechnology 58 Pacira 57 Clonicel 57 Mipomersen 57 diabetic neuropathic pain 57 Cerovive 57 placebo controlled clinical 57 Patient Outcomes 57 elotuzumab 57 Inclinix 57 ThermoDox R 57 Milnacipran 57 efficacy tolerability 57 Idenix Pharmaceuticals 57 Retisert 57 CALGB 57 Pulmonary Arterial Hypertension 57 Viprinex 57 BNC# 57 isavuconazole 57 MOZOBIL 57 BEMA TM Fentanyl 56 Pirfenidone 56 Neuronetics 56 EndoTAG TM -1 56 rEEG 56 Regado Biosciences 56 Auxilium Pharmaceuticals 56 Amrubicin 56 sunitinib malate 56 alvimopan 56 Phase 1b trial 56 tasimelteon 56 FavId 56 ixabepilone 56 QTinno 56 Presents Positive 56 EXPAREL 56 Vilazodone 56 enzastaurin 56 Cethromycin 56 pharmacokinetic PK 56 bosutinib 56 OncoVEX GM CSF 56 OMS# 56 Corcept Therapeutics 56 Phase 2a trial 55 Phase 2b clinical 55 AeroLEF TM 55 DDP# 55 Acadia Pharmaceuticals 55 pharmacoeconomic 55 dacetuzumab 55 KRN# 55 ISTA Pharmaceuticals 55 prospective multicenter 55 Carfilzomib 55 NeuroStar TMS Therapy 55 faropenem 55 Nanobody 55 Phase 2b clinical trials 55 ACZ# 55 relapsed multiple myeloma 55 INCB# [001] 55 GLPG# 55 Phase 2a clinical 55 ACRIN 55 Gemin X 55 HealthCore 55 NASDAQ CBST 55 nonclinical studies 55 Proxinium TM 55 Inc Therapeutic Competitors 55 Anika Therapeutics 55 PsychoGenics 55 Phase IIa clinical 55 EVEREST II